DigestRedComo funciona
Red
/
Empresas
OK
No verificado

OKYO Pharma LTD

Sobre qué escribimos

Anuncios brevesBiotecnologíaFinanzasFondos de inversiónMedicina Salud Bienestar

15 Comunicados de prensa

Ver todos los comunicados de prensa
19/05/2026
Biotecnología
OKYO Expands Scientific Advisory Board with the Appointment of International Expert Marta Sacchetti, MD, PhD
Fuente
OKYO Pharma LTD
Editor
GLOBENEWSWIRE
1.00
0
29/04/2026
Biotecnología
OKYO CEO and CSO to Present and Leadership Team to Participate at Upcoming Scientific Conferences in May
Fuente
OKYO Pharma LTD
Editor
GLOBENEWSWIRE
1.00
0
07/04/2026
Biotecnología
Medicina Salud Bienestar
OKYO Pharma Announces Scientific Advisory Board Meeting and Urcosimod Data Presentation During ASCRS Annual Meeting
Fuente
OKYO Pharma LTD
Editor
GLOBENEWSWIRE
1.00
0
19/03/2026
Biotecnología
Finanzas
OKYO Pharma Announces Chairman and Founder Acquires Shares
Fuente
OKYO Pharma LTD
Editor
GLOBENEWSWIRE
1.00
0
19/03/2026
Biotecnología
Finanzas
OKYO Pharma Announces Director Acquires Shares
Fuente
OKYO Pharma LTD
Editor
GLOBENEWSWIRE
1.00
0
19/03/2026
Biotecnología
Medicina Salud Bienestar
OKYO Pharma Announces Chief Development Officer and Director Acquires Shares
Fuente
OKYO Pharma LTD
Editor
GLOBENEWSWIRE
1.00
0
18/03/2026
Biotecnología
Anuncios breves
OKYO Pharma Reports New Phase 2 Data Demonstrating Meaningful Improvements in Patient-Reported Quality of Life Outcomes with Urcosimod in Neuropathic Corneal Pain
Fuente
OKYO Pharma LTD
Editor
GLOBENEWSWIRE
1.00
0
23/02/2026
Biotecnología
Medicina Salud Bienestar
OKYO Abstract Selected for Presentation at Premier Global Ophthalmology Congress
Fuente
OKYO Pharma LTD
Editor
GLOBENEWSWIRE
1.00
0
12/02/2026
Biotecnología
Finanzas
Medicina Salud Bienestar
OKYO Pharma Announces Pricing of $20 Million Public Offering of Ordinary Shares
Fuente
OKYO Pharma LTD
Editor
GLOBENEWSWIRE
1.00
0
12/02/2026
Biotecnología
Fondos de inversión
OKYO Pharma Announces Public Offering of Ordinary Shares
Fuente
OKYO Pharma LTD
Editor
GLOBENEWSWIRE
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0